Drug Eluting Stent Market anticipated to surpass US$17.049 billion by 2030 at a CAGR of 8.20%
The drug eluting stent market is anticipated to grow at a CAGR of 8.20% from US$11.499 billion in 2025 to US$17.049 billion by 2030.
The global drug eluting stent market is expected to experience significant growth in the coming years, driven by the increasing demand for minimally invasive procedures and the rising prevalence of cardiovascular diseases.
The use of drug eluting stents has become increasingly popular in recent years due to their ability to reduce the risk of restenosis and improve patient outcomes. These stents are coated with a drug that helps prevent the re-narrowing of the arteries after an angioplasty procedure. This has led to a shift towards minimally invasive procedures, as they offer faster recovery times and lower risk of complications compared to traditional open surgeries.
The report also highlights the growing prevalence of cardiovascular diseases as a major factor driving the demand for drug eluting stents. With the increasing adoption of unhealthy lifestyles and aging population, the incidence of heart diseases has been on the rise. This has created a significant demand for effective treatment options, further fueling the growth of the drug eluting stent market.
In addition, the market is also witnessing a surge in research and development activities, leading to the introduction of innovative products with improved efficacy and safety profiles. This has attracted investments from major players in the healthcare industry, further boosting the growth of the market.
Overall, the drug eluting stent market is expected to witness robust growth in the coming years, driven by the increasing demand for minimally invasive procedures and the rising prevalence of cardiovascular diseases. With advancements in technology and growing investments in research and development, the market is poised for further expansion. This presents lucrative opportunities for both existing and new players in the market.
Access sample report or view details: https://www.knowledge-sourcing.com/report/drug-eluting-stent-market
As a part of the report, the major players operating in the drug eluting stent market that have been covered are Abbott Cardiovascular, Boston Scientific Corporation, Medtronic Plc, Biotronik, Terumo Corporation, MicroPort Scientific Corporation, Biosensors International, Alvimedica, Lepu Medical Technology, MedicalExpo, Cook Medical, among others.
The market analytics report segments the drug eluting stent market as follows:
• By Coating Type
o Polymer-Based Coating
o Polymer-Free Coating
• By Application
o Coronary Artery Disease (CAD)
o Peripheral Artery Disease (PAD)
• By End-User
o Hospitals
o Ambulatory Surgical Centers
o Others
• By Geography
• North America
o USA
o Canada
o Mexico
• South America
o Brazil
o Argentina
o Others
• Europe
o Germany
o UK
o France
o Spain
o Others
• Middle East and Africa
o UAE
o Israel
o Others
• Asia Pacific
o China
o Japan
o South Korea
o India
o Indonesia
o Taiwan
o Thailand
o Others
Companies Profiled:
• Abbott Cardiovascular
• Boston Scientific Corporation
• Medtronic Plc
• Biotronik
• Terumo Corporation
• MicroPort Scientific Corporation
• Biosensors International
• Alvimedica
• Lepu Medical Technology
• MedicalExpo
• Cook Medical
• B. Braun
• Biotronik
• MicroPort Scientific Corporation
• Sahajanand Medical Technologies
Reasons for Buying this Report:-
• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do Businesses use our Reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Report Coverage:
• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Explore More Reports:
• Global Cardiovascular Stent Market: https://www.knowledge-sourcing.com/report/global-cardiovascular-stent-market
• Global Smart Medical Device Market: https://www.knowledge-sourcing.com/report/global-smart-medical-devices-market
• Global Airway Stent Market: https://www.knowledge-sourcing.com/report/global-airway-stent-market
• Surgical Equipment Market: https://www.knowledge-sourcing.com/report/surgical-equipment-market
• Global Smart Medical Device Market: https://www.knowledge-sourcing.com/report/global-smart-medical-devices-market
About Us
Knowledge Sourcing Intelligence (KSI) is a market research and intelligence provider that uses a combination of quantitative and qualitative research techniques to deliver comprehensive, in-depth insights to clients. Our approach to market research is centered around the concept of 'Knowledge Sourcing' - the process of gathering data and insights from multiple sources to create a comprehensive and well-rounded picture of the market. KSI's core services include market intelligence, competitive intelligence, customer intelligence, and product intelligence. KSI's approach to market research is designed to help clients make informed decisions, identify opportunities, and gain a better understanding of their target markets. By using a combination of primary and secondary research techniques, we provide clients with detailed insights into current market trends, customer profiles, competitor analysis, and product performance. KSI's market research and intelligence services enable clients to make informed decisions, develop strategic plans, and identify areas of opportunity.
Harsh Sharma
Knowledge Sourcing Intelligence LLP
+1 850-250-1698
info|knowledge-sourcing.com| |info|knowledge-sourcing.com
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Global Home Blood Pressure Monitoring Devices Market Forecast To Reach $4.52 Billion By 2029 With 13.3% Annual Growth
Hair Removal Devices Market Report 2025: Personal Grooming Awareness Drives Growth to $3.88 Billion by 2029
Global High-End Cellomics Market Outlook 2025–2034: M&A Trends, Expansion Strategies & Competitive Benchmarking
Kalendarium
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Farmacja

Zagrożenie krztuścem pozostaje najwyższe od ponad trzech dekad. Odporność utrzymuje się do 10 lat po szczepieniu
W ubiegłym roku na krztusiec zachorowało ponad 32 tys. osób. To ok. 35 razy więcej niż rok wcześniej. Ostatnie tygodnie przynoszą wyhamowanie tendencji wzrostowej, ale Główny Inspektor Sanitarny przestrzega przed tą groźną chorobą i wskazuje na konieczność szczepień u dzieci już w okresie niemowlęcym i szczepień przypominających u dorosłych. Dużą rolę w promowaniu tej jedynej formy profilaktyki odgrywają pielęgniarki, które nie tylko informują o korzyściach ze szczepień, ale też mogą do nich kwalifikować.
Bankowość
Zdaniem 80 proc. Polaków ceny nieruchomości są wysokie lub bardzo wysokie. Mimo to i tak wolimy posiadać na własność, niż wynajmować

Tylko 26 proc. Polaków uważa, że mamy obecnie dobry moment na zakup nieruchomości. Dla ośmiu na 10 ankietowanych ceny nieruchomości są obecnie wysokie lub bardzo wysokie. 65 proc. ocenia też, że niewiele osób z ich otoczenia może sobie teraz pozwolić na zakup mieszkania lub domu – wynika z badania „To my. Polacy o nieruchomościach” portalu ogłoszeniowego Nieruchomosci-online.pl.
Transport
Nowe opłaty za emisję CO2 mogą spowodować wzrost kosztów wielu małych i średnich firm. Eksperci apelują o mądre instrumenty wsparcia [DEPESZA]

System ETS2, który zacznie obowiązywać od 2027 roku, nałoży podatek na paliwa kopalne wykorzystywane do ogrzewania budynków czy w transporcie. Koszty w dużej mierze poniosą dostawcy, w tym małe i średnie firmy. – Potencjalny wpływ systemu ETS2 na sektor MŚP w Polsce będzie znacznie mniej drastyczny, niż mogłoby się wydawać. Konieczne jest jednak przygotowanie odpowiednich instrumentów, które wesprą przedsiębiorców w przemianie w kierunku niskoemisyjnym, ale jednocześnie będą unikały podwójnej kompensacji – wskazuje raport WiseEuropa pt. „Wędka czy ryba? Wsparcie dla polskich MŚP w związku z wprowadzeniem ETS2”.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.